Menopause is clinically diagnosed as a condition when a woman has not menstruated for
one year. During the menopausal transition period, there is an emergence of various lipid …

The definition of metabolic syndrome (MetS) has undergone several changes over the years
due to the difficulty in establishing universal criteria for it. Underlying the disorders related to …

Menopause is a risk factor for cardiometabolic diseases, including metabolic syndrome
(MetS), type 2 diabetes, and cardiovascular diseases. MetS is a constellation of …

Background and aims The metabolic syndrome (MetS) is a cluster of coexisting
cardiovascular risk factors. The role of specific dietary fats was reemphasized by dietary …

Background & aims Previous studies suggest that polyunsaturated fatty acids (PUFAs) may
reduce the risk of metabolic diseases, but some have shown ambiguous results. The aim of …

Background and aim Effects of long-chain omega-3 (LCn3) and omega-6 fatty acids on
prevention and treatment of inflammatory bowel diseases (IBD, including Crohn's Disease …

Metabolic syndrome (MetS) is a highly prevalent condition defined by the presence of at
least three out of five risk factors including central obesity, increased fasting glucose, high …

It is now recognized that the amount and type of dietary fat consumed play an important role
in metabolic health. In humans, high intake of polyunsaturated fatty acids (PUFAs) has been …

Omega-3 polyunsaturated fatty acids (PUFA) have demonstrated anti-inflammatory
properties, while Omega-6 have pro-inflammatory effects, and the balance between the two …

The purpose of this study was to explore the effect of omega-3 polyunsaturated fatty acids (n-
3 PUFAs) supplementation on serum lipid profile and blood pressure in patients with …